Maternal efforts to prevent type 1 diabetes in at-risk children

Diabetes Care

Volumn 28, Issue 4, 2005, Pages 916-921

  Baughcum, Amy E ^a   Johnson, Suzanne Bennett ^b   Carmichael, Stacy K ^b   Lewin, Adam B ^c   She, Jin Xiong ^d   Schatz, Desmond A ^e  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFFECT; ANXIETY; COGNITION; COPING BEHAVIOR; DIET; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERVIEW; NEWBORN SCREENING; PHYSICAL ACTIVITY; REVIEW; RISK MANAGEMENT; SELF MONITORING; STRESS;

ADULT; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS, TYPE 1; DIET; EXERCISE; FEMALE; GENETIC MARKERS; GENETIC SCREENING; HEALTH BEHAVIOR; HLA-DQ ANTIGENS; HUMANS; INCOME; INTERVIEWS; MALE; MOTHER-CHILD RELATIONS; MOTHERS; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 15944409253     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.4.916     Document Type: Review

References (25)

1. Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Norris JM, Klingensmith GJ, Rewers M: Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 27:1399-1404, 2004
2. Schatz DA, Muir A, Fuler K, Atkinson M, Crockett S, Hsiang H, Winter B, Ellis T, Taylor K, Saites C, Dukes M, Fang Q, Clare-Salzer M, She J: Prospective assessment in newborns for diabetes autoimmunity (PANDA): a newborn screening program in the general population of Florida (Abstract). Diabetes 49:67A, 2000
3. Nejentsev S, Sjöroos M, Soukka T, Knip M, Simel O, Lövgren T, Ilonen J: Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med 16:985-992, 1999
4. Ziegler AG, Hummel M, Schenker M, Bonifacio E: Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460-468, 1999
5. Patenaude AF, Guttmacher AE, Collins FS: Genetic testing and psychology: new roles, new responsibilities. Am Psychol 57:271-282, 2002
6. Ross LF: Minimizing risks: the ethics of predictive diabetes mellitus screening research in newborns. Arch Pediatr Adolesc Med 157:89-95, 2003
7. Roth R: Psychological and ethical aspects of prevention trials. J Pediatr Endocrinol Metab 14:669-674, 2001
8. Galatzar A, Green E, Ofan R, Benzzaquen H, Yosefsberg A, Wentrob N, Karp M, Vardi P: Psychological impact of islet cell antibody screening. J Pediatr Endocrinol Metab 14:675-679, 2001
9. Johnson SB, Riley WJ, Hansen CA, Nurick MA: Psychological impact of islet-cell antibody screening: preliminary results. Diabetes Care 13:93-97, 1990
10. Johnson SB, Tercyak KP: Psychological impact of islet cell antibody screening for IDDM on children, adults and their family members. Diabetes Care 18:1370-1372, 1995
11. Johnson SB, Carmichael SK: At-risk for diabetes: coping with the news. J Clin Psychol Med Settings 7:9-78, 2000
12. Johnson SB, Baughcum AE, Carmichael SK, She JX, Schatz DA: Maternal anxiety associated with newborn genetic screening for type 1 diabetes. Diabetes Care 27:392-397, 2004
13. Carmichael SK, Johnson SB, Baughcum AE, North K, Dukes M, She J, Schatz DA: Prospective Autoimmunity Newborn Diabetes Assessment (PANDA): maternal understanding of infant diabetes risk. Genet Med 5:1-7, 2003
14. Akerblom H, Knip M: Putative environmental factors in type 1 diabetes. Diabetes Metab 14:31-67, 1998
15. Hendrieckx C, DeSmet F, Kristoffersen I, Bradley C: Risk assessment for developing type 1 diabetes: intentions of behavioural changes prior to risk notification. Diabetes Metab Res Rev 18:36-42, 2002
16. Johnson SB: Participant experiences in the DPT-1: preliminary results. In NIH Type 1 TrialNet Study Group. Bethesda, MD, National Institutes of Health, 2002
17. Carmichael SK, Johnson SB, Fuller KG, Taylor KR, She JX, Schatz DA: Newborn genetic screening for type 1 diabetes: psychological impact and factors predicting continued participation (Abstract). Diabetes 48:A322, 1999
18. Bradley C: Diabetes Onset Locus of Control (DOLoC). In Handbook of Psychology and Diabetes. Bradley C, Ed. Chur, Switzerland, Harwood Academic, 1994, p. 397
19. Spielberger CD, Gorsuch RL, Lushene RE: STAI Manual. Palo Alto, CA, Consulting Psychologist Press, 1970, p. 23-49
20. Folkman S, Lazarus R: An analysis of coping in a middle-ages community sample. J Health Soc Behav 21:219-239, 1980
21. Vitaliano PP, Russo, Carr JE, Maiure RD, Becker J: The Ways of Coping Checklist: revision and psychometric properties. Multivariate Behav Res 20:3-26, 1985
22. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
23. Meiser B, Butow P, Friedlander M, Schnieden V, Gattas M, Kirk J, Suthers G, Haan E, Tucker K: Intention to undergo prophylactic mastectomy in women at increased risk of developing hereditary breast cancer. J Clin Oncol 18:2250-2257, 2000
24. Ritvo P, Irvine J, Robinson G, Brown L, Murphy KJ, Matthew A, Rosen B: Psychological adjustment to familial-genetic risk assessment for ovarian cancer: predictors of nonadherence to surveillance recommendations. Gynecol Oncol 84:72-80, 2002
25. Diefenbach MA, Wilier DM, Daly MB: Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. Health Psychol 18:532-536, 1999